Connect Biopharma Holdings (CNTB) Cash from Operations (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Cash from Operations of 16005000.0 for Q1 2026, down 42.27% sequentially from 11250000.0 in Q4 2025, and down 60.71% YoY from 40734422.44 in Q1 2025.
Connect Biopharma Holdings (CNTB) Cash from Operations (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Cash from Operations for 3 years, with the latest figure at 16005000.0 in Q1 2026.
- Quarterly Cash from Operations fell 60.71% year-over-year to 16005000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 57252000.0 (down 73.6% YoY) and the FY2025 annual result came in at 51206000.0, down 116.86% from the prior year.
- Cash from Operations slipped to 16005000.0 in Q1 2026 per CNTB's latest filing, from 11250000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 591000.0 in Q1 2024 and troughed at 17406000.0 in Q3 2025.
- A 3-year average of 10091444.44 and a median of 11250000.0 in 2025 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 33.82% in 2025, down 1585.11% in 2025.
- Over 3 years, Cash from Operations stood at 2319000.0 in 2024, then sank by 385.12% to 11250000.0 in 2025, then sank by 42.27% to 16005000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 16005000.0, 11250000.0, and 17406000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | -15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.92 Mn |
| Jun 30, 2026 | -15.92 Mn |
| Mar 31, 2026 | -16.01 Mn |
| Mar 31, 2026 | -16.01 Mn |
| Dec 31, 2025 | -11.25 Mn |
| Dec 31, 2025 | -11.25 Mn |
| Sep 30, 2025 | -17.41 Mn |
| Sep 30, 2025 | -17.41 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Mar 31, 2025 | -9.96 Mn |
| Mar 31, 2025 | -9.96 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Mar 31, 2024 | -591,000.00 |
| Mar 31, 2024 | -591,000.00 |